Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

由 Møller Pål
出版 2004-12-01

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

由 Møller, Pål
出版 2004

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care

由 Møller, Pål
發表在 Hered Cancer Clin Pract (2020)

The BRCA2 variant c.68-7 T>A is associated with breast cancer

由 Møller, Pål, Hovig, Eivind
發表在 Hered Cancer Clin Pract (2017)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

由 Møller, Pål, Hovig, Eivind
發表在 Hered Cancer Clin Pract (2018)

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

由 Møller, Pål, Hovig, Eivind
發表在 Med Health Care Philos (2017)

Costs and Benefits of Diagnosing Familial Breast Cancer

由 Heimdal, Ketil, Mæhle, Lovise, Møller, Pål
出版 1999

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

由 Tharmaratnam, Kukatharmini, Hagen, Anne Irene, Møller, Pål
發表在 Breast Cancer Res Treat (2014)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

由 Møller, Pål, Mæhle, Lovise, Clark, Neal, Apold, Jaran
出版 2007

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations

由 Reichelt, Jon G., Dahl, Alv A., Heimdal, Ketil, Møller, Pål
出版 1999

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift

由 Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
發表在 Cancers (Basel) (2019)

Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11...

由 Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
發表在 Cancers (Basel) (2020)

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

由 Seppälä, Toni T., Dominguez-Valentin, Mev, Sampson, Julian R., Møller, Pål
發表在 Fam Cancer (2020)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

由 Stormorken, Astrid, Heintz, Karen-Marie, Andresen, Per Arne, Hovig, Eivind, Møller, Pål
出版 2006

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

由 Borg, Åke, Dørum, Anne, Heimdal, Ketil, Mæhle, Lovise, Hovig, Eivind, Møller, Pål
出版 1999

Survival in Norwegian BRCA1 mutation carriers with breast cancer

由 Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
出版 2009

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

由 Heramb, Cecilie, Ekstrøm, Per Olaf, Tharmaratnam, Kukatharmini, Hovig, Eivind, Møller, Pål, Mæhle, Lovise
發表在 Hered Cancer Clin Pract (2015)

Germline PTEN mutations are rare and highly penetrant

由 Rustad Cecilie F, Bjørnslett Merete, Heimdal Ketil R, Mæhle Lovise, Apold Jaran, Møller Pål
出版 2006-12-01

Germline PTEN mutations are rare and highly penetrant

由 Rustad, Cecilie F, Bjørnslett, Merete, Heimdal, Ketil R, Mæhle, Lovise, Apold, Jaran, Møller, Pål
出版 2006

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

由 Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise
出版 2014